​MedLife, the largest private healthcare network in Romania, continues to strengthen its Group-level oncology facilities and announces the opening of an integrated gynecological oncology center located in MedLife’s largest hospital in Bucharest. The new center of excellence in the diagnosis, treatment and monitoring of patients affected by tumors in the gynecological field has an individual approach in accordance with the international protocols of ESGO (European Society of Gynecological Oncology) and a multidisciplinary team consisting of surgeons. , oncologists, radiation therapists, as well as specialists in psychology and physical therapy.

• The new center of excellence in the diagnosis, treatment and monitoring of patients affected by gynecological tumors is located in the largest MedLife hospital in Bucharest.
• The center is coordinated by Dr. Gabriel Mitra and is the result of a collaboration between Life Memorial Hospital, Bucharest Endometriosis Center and Neolife Medical Center.
• Patients benefit from the expertise of a multidisciplinary team and integrated surgery, oncology and radiotherapy services according to international protocols.
• MedLife Group continues to strengthen its oncology segment with plans for the coming year, including the opening of a new niche medical department in the Oltenia area.

The Center for Gynecological Oncology is the result of a collaboration between the largest MedLife Hospital in Bucharest – Life Memorial Hospital, Bucharest Endometriosis Center and the Neolife medical center, which is part of the same group.

“Oncology and radiotherapy have become MedLife’s priorities since 2021, when we expanded our facilities across the country through the acquisition of Neolife Cancer Centers and Brasov Cancer Hospital. Two acquisitions have added to the capabilities offered in this direction since 2019, with the integration of the OncoTeam pathological anatomy laboratory in Bucharest into the Group. Thus, the opening of an integrated gynecological oncology center, staffed by good doctors and state-of-the-art equipment, is a natural step in our mission to provide patients with international standard medical services.” said Doreen Preda, CEO of MedLife Group.

Integrated services of surgery, oncology and radiation therapy

Official statistics show that 20% of cancers diagnosed in Romanian women are gynecological. Of these, cervical cancer is the most common, followed by ovarian and endometrial cancer. In addition to these malignancies, breast cancer is the leading cause of cancer death among women.

Patients with one of these conditions can benefit from comprehensive care at the MedLife Gynecologic Oncology Center using a multidisciplinary approach. The medical team includes surgeons with more than 10 years of experience in minimally invasive gynecological surgery and more than 5,000 interventions in the field of pelvic oncology, Neolife oncologists and radiation therapists, as well as psychologists and physiotherapists who provide moral support and individual care. all patients

“This project was born as a result of a large number of oncological cases for which our help is requested. We wanted to offer them complex and complete treatment according to the highest European standards. Oncological gynecological surgery, like surgery for deep endometriosis, requires a multidisciplinary approach, and by collaborating with MedLife Group, we provide our patients with easy access, in an integrated system, to the best solutions for diagnosis, treatment and monitoring“, said Dr. Gabriel Mitroi, obstetrician-gynecologist with super-specialization in endometriosis surgery and gynecological cancer surgery and coordinator of the Bucharest Endometriosis Center.

Robotic surgery in the treatment of gynecological cancers

Gynecologic cancer surgery requires extensive experience, exceptional surgical skills, and access to the most advanced treatments and technologies. At the Gynecologic Oncology Center, patients can benefit from robotic surgery using the da Vinci Xi system. Almost all surgical interventions in the center (with the exception of common ovarian neoplasms) are performed using minimally invasive methods.

Robotic surgery is an alternative to conventional laparoscopic surgery, known for the precision, efficiency and safety of surgical interventions. It is also used as a less invasive tool for determining the extent of the disease, as well as for the possibility of resection within the oncological limits of tumors of the genital organs.

For patients suffering from gynecological tumors, the robotic approach offers the advantage of a significantly faster recovery and minimal impact on quality of life. In contrast to the classic intervention, the operations carried out with the help of robots involve a significantly reduced risk of bleeding, a reduction in the risk of infection, minimization of postoperative discomfort and possible adverse side effects in the case of complex interventions.

***

About the MedLife medical system

The MedLife medical system was founded almost three decades ago, successfully developed and became the largest network of private medical services in Romania. The Romanian entrepreneurs who laid the foundations of this company invested and participated in the changes in the Romanian healthcare system, believed in innovation and dared to reach the highest possible goals to offer Romanian patients quality, professionalism, care and respect for them. need.

The company manages the most extensive network of clinics, one of the largest networks of medical laboratories, general and specialized hospitals and has the largest base of corporate clients of Health Prevention Packages in the country. In terms of sales, it is also one of the largest private healthcare players in Central and Eastern Europe.

MedLife Group has a successful track record of both organic growth and acquisition growth. Its strong and experienced management team has been able to create and manage these growth opportunities, gaining valuable knowledge and experience to enable it to find the best path for continued successful expansion.

Being a Romanian company with traditions, MedLife chose to list on the Romanian Stock Exchange, being a model of listing on the local capital market. He opened up horizons, and thanks to the corporate governance he introduced, he inspired other local companies to follow this path and help the development of Romanian capital and economy. The shares issued by MedLife SA are admitted to trading on the regulated spot market administered by the Bucharest Stock Exchange, premium category, with the trading symbol ″M″.

During the pandemic, MedLife managed to play an important role in society and gain leadership status in monitoring the pandemic through active participation in the research field. The company continues to invest in technology and infrastructure projects that impact the local community. It creates jobs and develops an ecosystem that contributes to the development and maintenance of a healthy Romania.

Article supported by MedLife